FDA committee gives new antibiotic mixed endorsement.
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D048628:Ketolides; D018942:Macrolides; D011014:Pneumonia / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D000900:Anti-Bacterial Agents; D048628:Ketolides; D018942:Macrolides; C106791:telithromycin